Showing results (261-270 of 1,750) with videos related to
Sort By:
Pageof 175
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 2, 2009
Intratumoral but not systemic delivery of CpG oligodeoxynucleotide augments the efficacy of anti-CD20 monoclonal antibody therapy against B cell lymphomaDavid J Betting, Reiko E Yamada, Kamran Kafi, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 2, 2009
Melan-A/MART1 analog peptide triggers anti-myeloma T-cells through crossreactivity with HM1.24Olaf Christensen, Alaviana Lupu, Stefanie Schmidt, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 2, 2009
Engineering and biological characterization of VB6-845, an anti-EpCAM immunotoxin containing a T-cell epitope-depleted variant of the plant toxin bouganinJeannick Cizeau, Danielle M Grenkow, Jennifer G Brown, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2009
Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cellsLucie Leveque, Florence Deknuydt, Gilles Bioley, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2009
Virus-like particle (VLP) lymphatic trafficking and immune response generation after immunization by different routesRafael Cubas, Sheng Zhang, Sunkuk Kwon, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2009
Synergy between dendritic cells and GM-CSF-secreting tumor cells for the treatment of a murine renal cell carcinomaGregory Driessens, Paul Hoffmann, Michael Pouwels, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2009
Using CD40-activated B cells to efficiently identify epitopes of tumor antigensEisei Kondo, Luise Gryschok, Joachim L Schultze, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2009
Manufacturing validation of biologically functional T cells targeted to CD19 antigen for autologous adoptive cell therapyDaniel Hollyman, Jolanta Stefanski, Mark Przybylowski, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 27, 2009
Inhibition of TGFbeta1 makes nonimmunogenic tumor cells effective for therapeutic vaccinationPu Liu, Jade Jaffar, Yifeng Zhou, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 27, 2009
Multiple antigen-targeted immunotherapy with alpha-galactosylceramide-loaded and genetically engineered dendritic cells derived from embryonic stem cellsSatoshi Fukushima, Shinya Hirata, Yutaka Motomura, et al.Pageof 175